IT PAYS TO COMPARE: ASSISTING MEDICARE PART D BENEFICIARIES WITH ENROLLMENT YIELDS OUT-OF-POCKET COST SAVINGS

被引：6
|
作者：
Geonnotti, Kristin L. [1 ]
Upchurch, Gina
Roth, Mary T. [2 ]
Weinberger, Morris [1 ,3 ]
机构：
[1] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Div Pharmaceut Outcomes & Policy, UNC Eshelman Sch Pharm, Chapel Hill, NC USA
[3] Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2011年 / 59卷 / 05期
关键词：
D O I：
10.1111/j.1532-5415.2011.03383.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：953 / 955
页数：4
相关论文
共 50 条
  • [41] Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries
    Gross, DJ
    Alecxih, L
    Gibson, MJ
    Corea, J
    Caplan, C
    Brangan, N
    HEALTH SERVICES RESEARCH, 1999, 34 (01) : 241 - 254
  • [42] Out-of-pocket (OOP) health care expenditure burden for Medicare beneficiaries with cancer.
    Zuckerman, Ilene H.
    Pandya, Naimish B.
    Stuart, Bruce C.
    Shaffer, Thomas
    Erten, Mujde Z.
    Ke, Xuehua
    Shoemaker, J. Samantha
    Tai, Ming-Hui
    Davidoff, Amy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease
    Kazi, Dhruv S.
    DeJong, Colette
    Chen, Randi
    Wadhera, Rishi K.
    Tseng, Chien-Wen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (21) : 2103 - 2111
  • [44] Impact of Medicare Part D on out-of-pocket drug costs and utilization for patients with cancer.
    Kircher, Sheetal Mehta
    Johansen, Michael
    Davis, Matthew M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [45] Impact of Medicare Part D on Out-of-Pocket Drug Costs and Medical Use for Patients With Cancer
    Kircher, Sheetal M.
    Johansen, Michael E.
    Nimeiri, Halla S.
    Richardson, Caroline R.
    Davis, Matthew M.
    CANCER, 2014, 120 (21) : 3378 - 3384
  • [46] Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D
    Yazdany, Jinoos
    Dudley, R. Adams
    Lin, Grace A.
    Chen, Randi
    Tseng, Chien-Wen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 931 - 933
  • [47] Out-of-pocket cost trends for Medicare patients with newly diagnosed cancer
    Narang, Amol
    Nicholas, Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGS
    Sepulveda, B.
    Doyle, J.
    White, C.
    VALUE IN HEALTH, 2011, 14 (03) : A15 - A16
  • [49] The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures
    Yin, W.
    Basu, A.
    Zhang, J.
    Rabbani, A.
    Meltzer, D.
    Alexander, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 620 - 620
  • [50] Impact of Medicare Part D on Out-of-Pocket Prescription Drug Costs among Elderly with Diabetes
    Choi, Yoon Jeong
    Jia, Haomiao
    Gross, Tal
    Weinger, Katie
    Stone, Patricia W.
    Smaldone, Arlene M.
    DIABETES, 2015, 64 : A70 - A70
12345